Results 111 to 120 of about 1,067 (157)
Case Report: Life-threatening Kasabach-Merritt phenomenon in a 2-month-old child. [PDF]
Front PediatrWong Grossman AV +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Journal of Cutaneous Medicine and Surgery, 2002
Background: Kasabach-Merritt syndrome (KMS) is a consumptive coagulopathy associated with the presence of a large vascular lesion. It is often a frustrating condition to treat and it carries a high mortality rate. There are currently no known treatment guidelines.
Sheilagh, Maguiness, Lyn, Guenther
openaire +3 more sources
Background: Kasabach-Merritt syndrome (KMS) is a consumptive coagulopathy associated with the presence of a large vascular lesion. It is often a frustrating condition to treat and it carries a high mortality rate. There are currently no known treatment guidelines.
Sheilagh, Maguiness, Lyn, Guenther
openaire +3 more sources
Journal of Pediatric Surgery, 1988
Eight infants with hemangiomata associated with severe consumption coagulopathy are reviewed; three died. The presentations and method of management are discussed. The varied response to different modalities of therapy initiated this report and led to a search of the world literature in an attempt to identify the pattern of response, if any, to ...
M, el-Dessouky +3 more
openaire +2 more sources
Eight infants with hemangiomata associated with severe consumption coagulopathy are reviewed; three died. The presentations and method of management are discussed. The varied response to different modalities of therapy initiated this report and led to a search of the world literature in an attempt to identify the pattern of response, if any, to ...
M, el-Dessouky +3 more
openaire +2 more sources
The American Journal of the Medical Sciences, 1971
Abstract:Studies are presented on a 20-year-old man with congenital giant hemangioma occupying the whole left side of the body, with alterations in the clotting system characteristic of a consumption-coagulopathy with “defensive” fibrinolysis.
F, Rodriguez-Erdmann +3 more
openaire +2 more sources
Abstract:Studies are presented on a 20-year-old man with congenital giant hemangioma occupying the whole left side of the body, with alterations in the clotting system characteristic of a consumption-coagulopathy with “defensive” fibrinolysis.
F, Rodriguez-Erdmann +3 more
openaire +2 more sources
Nishi Nihon Hifuka, 1986
放射線治療が奏効し, 凝固線溶系異常が改善したKasabach-Merritt症候群の1例を報告し, 光顕的および電顕的所見, ならびに電子線照射と検査所見の正常化との関係について考按した。
Rieko WATANABE +6 more
openaire +1 more source
放射線治療が奏効し, 凝固線溶系異常が改善したKasabach-Merritt症候群の1例を報告し, 光顕的および電顕的所見, ならびに電子線照射と検査所見の正常化との関係について考按した。
Rieko WATANABE +6 more
openaire +1 more source
Kasabach–merritt syndrome: pathogenesis and management
British Journal of Haematology, 2001openaire +4 more sources
Kasabach-Merritt syndrome in infants
Journal of the American Academy of Dermatology, 1983Kasabach-Merritt syndrome consists of thrombocytopenia, microangiopathic hemolytic anemia, and an acute or chronic consumption coagulopathy in association with a rapidly enlarging hemangioma. Although the potential for serious morbidity is great, the condition remits when the hemangioma begins to involute.
openaire +2 more sources
Kasabach-Merritt Syndrome: Therapeutic Considerations
Pediatrics, 1987During the past 15 years we have managed six children with capillary hemangiomas in association with consumptive coagulopathy—the Kasabach-Merritt syndrome. Their ages when first seen ranged from 2 weeks to 4 years with a mean of 19 months. In three of the patients, the hemangiomas remained small for many months and then suddenly enlarged and ...
E C, Larsen +3 more
openaire +2 more sources
Radiotherapy in kasabach-merritt syndrome
Radiography, 1997Abstract A male infant was born with a 1 × 3 cm reddish lesion under his umbilicus which enlarged within a month and was associated with consumptive coagulopathy. A diagnosis of Kasabach-Merritt syndrome (KMS) was made. After no response to prednisolone and interferon-α treatment, 8 Gy of radiotherapy (2 Gy. day −1 ) was applied.
Esassolak M. +5 more
openaire +2 more sources